Factor | Callens_2015_MicrDrugResi (10258)

Enrofloxacin Use

Swine | Piglets

5

Description

Enrofloxacin Use in Piglet

Resistance Outcomes

Resistance Microbe Outcome
Ceftiofur
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin Use 1.70 42
No Use 0.00 821
Tetracycline
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin Use 57.10 42
No Use 35.00 821
Ampicillin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin Use 73.80 42
No Use 48.50 821
Enrofloxacin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin Use 47.60 42
No Use 7.10 821
Sulfadiazine And Trimethoprim
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin Use 40.50 42
No Use 22.50 821